$1.380
+0.143 (+10.39%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CMMB por análisis de gráficos similares
Alphio's CMMB stock price prediction model matches the current Chemomab Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.38 (-0.24%). The 1-week path is $1.41 (+2.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Chemomab Therapeutics Ltd?
Chemomab Therapeutics Ltd. (CMMB) appears to be a good buy right now, trading at $1.38, which is significantly below its 52-week high of $2.99, indicating potential upside. The stock has shown a strong 5-day change of +18.96%, suggesting positive momentum. However, the company has a negative net income with losses reaching -2,165,000 USD in Q2 2026, which presents a risk to consider.
CMMB cerró en $1.38 el Friday, tras subir +10.39%
Chemomab Therapeutics Ltd (CMMB) last closed at $1.3799, gaining +10.39%. These facts feed the 1-day and 1-week CMMB price prediction above.
Factores de la previsión
Los factores de la previsión de Chemomab Therapeutics Ltd (CMMB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CMMB, ordenadas por similitud.
Análisis de estacionalidad de CMMB
Historically the probability of a positive November return for CMMB is 45.45%. August offers the highest probability of a positive month at 62.50%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CMMB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.06 | $1.07 | $1.13 | -22.58% |
| Dec 2026 | $1.01 | $1.21 | $1.23 | -12.48% |
En 2026, se proyecta que Chemomab Therapeutics Ltd (CMMB) oscile entre $1.01 y $1.23.
Previsión mensual de Chemomab Therapeutics Ltd para 2026
En Nov de 2026, se proyecta que Chemomab Therapeutics Ltd promedie $1.07, con un mínimo de $1.06 y un máximo de $1.13.
En Dec de 2026, se proyecta que Chemomab Therapeutics Ltd promedie $1.21, con un mínimo de $1.01 y un máximo de $1.23.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.